Society of Toxicology (SOT) 2026 Annual Meeting and ToxExpo
Join Pharmaron at the SOT 2026 Annual Meeting and ToxExpo
March 22–25, 2026 | San Diego Convention Center
Pharmaron is proud to sponsor the 2026 Society of Toxicology Annual Meeting and ToxExpo in San Diego, CA as an exhibitor. The three-day ToxExpo is taking place March 23–25 from 9:00 AM to 4:30 PM, and will bring together leading scientists, research organizations, government agencies, and industry partners dedicated to advancing toxicology and human health.
Our scientific leaders and business development teams will be available at Booth #2134 to discuss your projects in depth. We look forward to learning how our safety assessment and toxicology capabilities can support the development and regulatory success of your small molecules, biologics, cell and gene therapy products, and medical devices.
Our SOT Annual Meeting and ToxExpo Schedule
Exhibit Hours
Exhibit Booth # 2134
- March 23 – 25, from 9:00 am to 4:30 pm
Talks and Posters
Join our Exhibitor-Hosted Session
Pharmaron is proud to present our exhibitor-hosted session titled, “A Holistic Approach to Toxicology and Bioanalysis of ADCs”
- Where: Room 23B
- When: Tuesday, March 24th, from 9:15–10:15 AM
Sr. Director Business Development
Safety Assessment
Director of Ophthalmology
Pharmaron presents a holistic approach to ADC toxicology, integrating physicochemical and ADME insights to enable meaningful interpretation. We address in vivo toxicology in cynomolgus monkeys and the complexity of ADC bioanalysis using LC?MS and LBA platforms, including hybrid and generic methods, to enable robust quantification during discovery and regulatory stages.
Don’t Miss Our Talk
Session 43, Visionary Foresight Symposium: Pioneering Cell-Based Therapies
- When: Wednesday, March 25, 2026
- Time: 8:00 -10:45 am
- Speaker: Sandeep Kumar, Ph.D., Director of Ophthalmology will speak in the Ocular Specialty Section; Biotechnology Specialty Section & Regulatory and Safety Evaluation Specialty Section.
- Talk Title: Enabling Breakthroughs in Ocular Disease: The Strategic Role of CROs in Cell Therapy Development
- Abstract: Cell-based therapies hold transformative potential for treating ocular diseases, offering innovative approaches for conditions that currently lack effective treatments. Their successful development, however, requires comprehensive and rigorous preclinical evaluation to ensure safety, efficacy, and alignment with regulatory expectations. Contract Research Organizations (CROs) play a pivotal role in supporting pharmaceutical and biotechnology sponsors throughout the nonclinical development pipeline. This presentation will highlight the strategic contributions of CROs in designing and executing ocular cell therapy studies that support safety and efficacy assessments—from early-stage planning through Investigational New Drug (IND)-enabling studies. Key focus areas include selecting appropriate and translational animal models, thorough characterization of the cell therapy product, precise surgical delivery techniques tailored for ocular administration, and advanced in vivo imaging modalities to monitor biodistribution, therapeutic effects and safety. The importance of adhering to Good Laboratory Practice (GLP) standards will also be discussed, as these are critical for ensuring data integrity, meeting regulatory requirements, and facilitating a smooth transition to first-in-human clinical trials.
Our Poster Presentations:
Monday, March 23, 2026
9:15 to 11:45 AM
- Poster title: In vitro evaluation of drug-induced kidney injury using cell painting assay in 2D and 3D kidney models
- Poster session title: Kidney
- Poster board number: A124
- Poster number: #3023
Monday, March 23, 2026
1:45 to 4:15 PM
- Poster title:The comprehensive cardiovascular toxicology assessment in multi-level of in vitro cell models
- Poster session title: New Approach Methods: In Vitro I
- Poster board number: G530
- Poster number: #3387
- Poster title: In vitro assessment of potential hematotoxicity of ADC drugs
- Poster session title: Pharmaceutical Safety and Drug Discovery
- Poster board number: J691
- Poster number: #3538
- Poster title: In Vitro Human Bronchiole Models as Promising Tools for Drug Screening with Potential Pulmonary Toxicity
- Poster session title: New Approach Methods: In Vitro I
- Poster board number: G531
- Poster number: #3388
- Poster title: Human Intestinal Organoids and Derived Barrier Models for High-Efficiency Assessment of Drug-Induced Gastrointestinal Toxicity
- Poster session title: Pharmaceutical Safety and Drug Discovery
- Poster board number: J686
- Poster number: #3533
Tuesday, March 24, 2026
9:15 to 11:45 AM
- Poster title: Method Qualification for the determination of Total antibody, ADC and free payload from ADC using LC-MS/MS
- Poster session title: Safety Assessment: Pharmaceutical–Drug Development I
- Poster board number: G521
- Poster number: #4047
- Poster title: Evaluation of Intravenous Oncolytic Virus Delivery in a Hamster Syngeneic Pancreatic Cancer Model
- Poster session title: Safety Assessment: Pharmaceutical–Drug Development I
- Poster board number: G525
- Poster number: #4051
- Poster title: A Translational 3D Spheroid Assay for Preclinical Assessment of Drug-Induced Liver Injury
- Poster session title: Liver: In Vitro
- Poster board number: A107
- Poster number:#3679
- Poster title: Untargeted Lipidomics Reveals Mechanistic Signatures of Drug Induced Hepatotoxicity in Rat Hepatocytes
- Poster session title: Liver: In Vitro
- Poster board number: A108
- Poster number:#3680
- Poster title: Phenotypic Profiling of Drug-Induced Liver Injury Using Cell Painting in 2D and 3D Human Hepatocyte Models
- Poster session title: Liver: In Vitro
- Poster board number: A109
- Poster number:#3681
- Poster title: Safety Profiling of Ocular Buffers in the Context of Posterior Segment Gene and Cell Therapeutics
- Poster number: #4338
- Poster session title: Ocular Toxicology
- Poster board number: M837
Wednesday, March 25, 2026
9:15 to 11:45 AM
- Poster title: In silico modeling of on-target and off-target safety pharmacology of oligonucleotides
- Poster session title: Liver: Computational Toxicology
- Poster board number: A121
- Poster number: #4368
See You in San Diego
We look forward to another year of scientific exchange, collaboration, and partnership at SOT 2026. Meet our team at Booth #2134 or join our Exhibitor-Hosted Session on March 24 to learn how Pharmaron’s scientific expertise and integrated global services can help bring your next program forward with confidence.
About the Society of Toxicology Annual Meeting
The SOT Annual Meeting and ToxExpo is a unique gathering of 5,000+ toxicologists and industry professionals. With 70 scientific sessions, over 2,000 poster presentations, and 250 exhibitors, this premier event dives deep into cutting-edge science and technology in toxicology. But it’s more than just science—a vibrant forum for networking, mentorship, and career advancement, with approachable experts and a collaborative atmosphere where innovation thrives. Connect with Pharmaron’s team at Booth #1062 to discover how our safety assessment services can elevate your projects. Register today.
Request a Meeting
Meeting Request Form
Meeting requests during a conference or event
